中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
23期
91-92
,共2页
老年失代偿期乙肝肝硬化%拉米夫定%阿德福韦脂
老年失代償期乙肝肝硬化%拉米伕定%阿德福韋脂
노년실대상기을간간경화%랍미부정%아덕복위지
The old age of liver cirrhosis%Lamivudine%Ade Phu Vee
目的：评价老年失代偿期乙肝肝硬化应用拉米夫定联合阿德福韦脂治疗效果。方法对照组35例口服阿德福韦脂治疗，观察组35例联合用拉米夫定联合阿德福韦脂治疗，对比不同用药治疗后效果。结果观察组患者的HBV DNA阴转率明显、Child—Pugh评分评分下降与对照组相比差异显著，P <0.05。结论拉米夫定联合阿德福韦脂治疗老年失代偿期乙肝肝硬化疗效显著。
目的：評價老年失代償期乙肝肝硬化應用拉米伕定聯閤阿德福韋脂治療效果。方法對照組35例口服阿德福韋脂治療，觀察組35例聯閤用拉米伕定聯閤阿德福韋脂治療，對比不同用藥治療後效果。結果觀察組患者的HBV DNA陰轉率明顯、Child—Pugh評分評分下降與對照組相比差異顯著，P <0.05。結論拉米伕定聯閤阿德福韋脂治療老年失代償期乙肝肝硬化療效顯著。
목적：평개노년실대상기을간간경화응용랍미부정연합아덕복위지치료효과。방법대조조35례구복아덕복위지치료，관찰조35례연합용랍미부정연합아덕복위지치료，대비불동용약치료후효과。결과관찰조환자적HBV DNA음전솔명현、Child—Pugh평분평분하강여대조조상비차이현저，P <0.05。결론랍미부정연합아덕복위지치료노년실대상기을간간경화료효현저。
Objective To evaluate the therapeutic effect of adefovir dipivoxil combined with elderly loss of decompensated liver cirrhosis with lamivudine. MethodsControl group 35 cases were treated by adefovir dipivoxil treatment, observation group of 35 cases combined with lamivudine combined with adefovir dipivoxil treatment. After comparing the different treatment effect.Results The DNA HBV negative conversion rate of the observation group was significantly lower than that of the control group, the difference was significant, P < 0.05.Conclusion Lamivudine combined with adefovir dipivoxil treatment of elderly patients with decompensated hepatitis B cirrhosis significantly.
